Concepedia

Patricia Cortez

PC

Statistics

Publications

3

Citations

306

H-Index

3

Active since

2022

Affiliations

MedSIR (Spain)(Current)

Hospital Ruber Internacional

Hospital Universitario Ramón y Cajal

Hospital Universitario Virgen del Rocío

Instituto Oncológico Dr. Rosell

Patricia Cortez is an author at MedSIR (Spain) specializing in immunotherapy, cancer immunotherapy, and medicine.

Publications per year

2022–2024

3

Publications

3

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial

José Manuel Pérez-García, Marta Vaz Batista, Patricia Cortez et al. · Neuro-Oncology · 2022 · 248 citations · Full text

Medicine, Oncology, Pharmacology +17

The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis

Marta Vaz Batista, José Manuel Pérez-García, Laia Garrigós et al. · Med · 2024 · 39 citations

Medicine, Oncology, Pharmacotherapy +16

Prevention of sacituzumab govitecan (SG)-related neutropenia and diarrhea in patients (pts) with triple-negative or HR+/HER2- advanced breast cancer (ABC; PRIMED): A phase 2 trial.

José Manuel Pérez García, María Gión, Manuel Ruíz‐Borrego et al. · Journal of Clinical Oncology · 2024 · 19 citations · Full text

Medicine, Oncology, Pharmacology +13

1–3 of 3